Trials / Completed
CompletedNCT00487214
Internet-based, Naturalistic Evaluation of Tolerability and Individual Patient Target Pressures With Bimatoprost 0.03% in Glaucoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 361 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the range of target IOPs set for glaucoma patients starting monotherapy with bimatoprost and to evaluate patient and physician satisfaction with bimatoprost in "real-world" settings
Conditions
Timeline
- Start date
- 2002-06-01
- Primary completion
- 2003-02-01
- Completion
- 2003-02-01
- First posted
- 2007-06-15
- Last updated
- 2011-06-01
Source: ClinicalTrials.gov record NCT00487214. Inclusion in this directory is not an endorsement.